What You Should Know:
- Foundation Medicine acquires Lexent Bio, a precision oncology company developing novel liquid biopsy platforms.
- The acquisition will accelerate Foundation Medicine’s liquid biopsy R&D and advance cancer care through an expansion of multiomics capabilities.
Foundation Medicine, Inc., announced that it has completed the acquisition
of Lexent Bio, Inc., a precision oncology
company located in California, developing novel multiomics liquid biopsy
platforms
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Cue Health Lands $100M to Scale Rapid, Portable, Point-of-Care COVID-19 Test
What You Should Know:
- Cue Health raises $100M to commercialize its portable, molecular diagnostic test capable of detecting SARS-CoV-2, the virus that causes COVID-19, in less than 25 minutes using a simple nasal swab.
- The test is part of the Cue Health Monitoring System, which is designed to be a portable device that can perform a molecular test and connect patients to a mobile health platform that features interventional components such as telemedicine
Read More
COVID-19 Clinical Trials: How AI-Based Chatbots Can Provide Pandemic-Level Execution
More than 500 new COVID-19 related clinical trials have been registered as of the end of April. The race to find a COVID-19 vaccine is on and the public spotlight is on clinical trials. Strangely named drugs such as Hydroxychloroquine and Remdesivir have become household names and are featured and debated regularly on the 24-hour news channels.
The pressure to find a cure is intense. The locked-down world does not want to hear that at best, we may find a vaccine sometime in 2021. What
Read More
Intravacc, EpiVax Team Up in Development of COVID-19 Emerging Vaccine
What You Should Know:
- Combines Intravacc's unique OMV delivery platform with
synthetically produced COVID-19 epitopes from EpiVax' immunoinformatics toolbox
- Goal is to generate safe and effective adaptive
immunity against SARS-CoV-2 and related coronaviruses
- Clinical studies anticipated to start in Q4 2020
Intravacc, one
of the world's leading translational research and development vaccine
institutes, with an extensive track record in developing viral and
Read More
Benchling Raises $50M to Scale Life Sciences R&D Platform & Fuel Biotech Innovations
What You Should Know:
- Today, life sciences R&D cloud platform Benchling announced a $50M Series D raise led by Alkeon and joined by new investors Spark Capital, Lux Capital and ICONIQ Partners, as well as existing investors Thrive Capital and Benchmark.
- This funding will help Benchling expand its product suite, providing vital collaboration tools for life science researchers to help embrace the complexity of biology and find breakthroughs faster.
Benchling, the leading
Read More
Oncology Analytics Lands $28M to Expand Oncology Capabilities
What You Should Know:
- Oncology Analytics raises $28M in Series C funding led by Baird Capital to expand its oncology-focused capabilities, accelerate real-world data and analytics solutions for health plans, and increase the market share of its technology-enabled utilization management solution.
- Oncology Analytics' prior authorization platform is used by physicians to support 5 million health plan members in the US and Puerto Rico and covers the full spectrum of therapeutics, across
Read More
COVID-19 Testing Every Nursing Home & Staff Would Cost $440M Nationwide
The American Health Care Association and National Center for Assisted Living (AHCA/NCAL) has released a state by state breakdown of the estimated cost to COVID-19 test every nursing home resident and staff just once, which would cost $440 million nationwide. As this shows, the cost of ongoing COVID-19 testing of nursing home residents and staff is unsustainable without additional funding and support from federal and state governments. Even the CDC’s recent recommendation to test all nursing
Read More
Philips Launches HealthSuite Clinical Trial Accelerator
What You Should Know:
Philips launches HealthSuite Clinical Trial Accelerator
to help life science organizations run more flexible, patient-centric clinical
trials.
Clinical Trial Accelerator enables patient-centric trials
at home, managing the collection of data while providing the security and
compliance expected from both patients and life science organizations.
Philips, today
announced Clinical
Trial Accelerator on Philips HealthSuite. This new tailored set of
capabilities
Read More
COVID-19 Testing Provider Curative Acquires KorvaLabs
What You Should Know:
COVID-19 testing provider Curative Acquires KorvaLabs, a
CLIA certified and DEA licensed analytical laboratory.
Easy to use, accurate, and rapidly scalable oral fluid test will continue to be produced and processed in KorvaLabs’ San Dimas, CA facilities.
COVID-19 testing startup Curative
Inc. announced today that it has completed the acquisition
of KorvaLabs, Inc., a CLIA certified and DEA licensed analytical
laboratory based in San Dimas,
Read More
FDA Approves Everlywell’s COVID-19 Test Home Collection Kit Using Nasal Swabs
What You Should Know:
- FDA approves Everlywell’s COVID-19 Test Home Collection Kit under the emergency use authorization (EUA) allows an individual to self-collect a nasal sample at home using Everlywell’s authorized kit.
- The Everlywell home-collection kit is currently the only authorized COVID-19 at-home sample collection kit for use with multiple authorized COVID-19 diagnostic tests.
The U.S. Food and Drug
Administration (FDA) has issued emergency use authorization (EUA) to
Read More
